Pembrolizumab (melanoma resubmission): Solution concentrate for I.V. infusion 100 mg in 4 ml; Keytruda® Page last updated: 3 July 2020 Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB) Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)